NICU Asthma Education and Secondhand Smoke Reduction Study
Preventing Respiratory Illness Among Premature Infants: An Asthma Education and Secondhand Smoke Reduction Study
1 other identifier
interventional
165
1 country
1
Brief Summary
Premature infants have a significantly increased risk for developing respiratory illnesses and asthma. Secondhand smoke (SHS) also is clearly associated with increased breathing problems in children, thus exposure to smoke makes it substantially more likely for a premature infant to develop wheezing. The overall goal of this study is to test whether comprehensive asthma education combined with a home-based secondhand smoke reduction program can reduce exposure to smoke and prevent respiratory illness among premature infants. Our hypotheses are:
- More premature infants whose families receive asthma education combined with a SHS reduction intervention will live in smoke-free environments compared to infants receiving only asthma education (control group).
- Caregivers receiving the SHS reduction program will have higher rates of quit attempts and less relapse into smoking compared to caregivers in the control group.
- Infants whose families receive the combined intervention will experience less respiratory illness compared to infants in the control group.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Feb 2007
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2007
CompletedFirst Submitted
Initial submission to the registry
July 10, 2007
CompletedFirst Posted
Study publicly available on registry
July 12, 2007
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2015
CompletedResults Posted
Study results publicly available
November 23, 2015
CompletedNovember 23, 2015
October 1, 2015
8.3 years
July 10, 2007
September 15, 2015
October 20, 2015
Conditions
Outcome Measures
Primary Outcomes (1)
Infants Living in Smoke-free Environments.
Infants living in homes with a "home smoking ban" rule
5 months post baseline
Secondary Outcomes (1)
Respiratory Morbidity Assessed Through Respiratory Symptoms as Well as Health Care Utilization for Respiratory Illnesses.
2, 5, and 7-9 months post baseline
Study Arms (2)
Secondhand Smoke Reduction and Asthma Education
EXPERIMENTALParents of children in the experimental group will receive asthma education at NICU discharge as well as a secondhand smoke reduction program.
Asthma Education
ACTIVE COMPARATORParents of children in the active comparator group will receive asthma education at NICU discharge.
Interventions
A secondhand smoke reduction program, including smoking cessation counseling (if appropriate), and feedback about the children's cotinine levels will be implemented using principles of Motivational Interviewing.
Asthma education will be provided at NICU discharge.
Eligibility Criteria
You may qualify if:
- ≤32 weeks gestation
- Planned discharge to home from the Neonatal Intensive Care Unit
- Parent or caregiver must consent to the intervention
- The first sibling discharged, for twins or infants from a multiple birth pregnancy
You may not qualify if:
- Inability to speak and understand English
- No access to a working phone for follow-up surveys (either at the subject's home or an easily accessible alternate home)
- Family residence outside the greater Rochester area (more than 30 miles away)
- Children in foster care or other situations in which guardian consent cannot be obtained
- The child having significant medical conditions, including serious heart disease, cystic fibrosis, or other conditions that could interfere with the assessment of respiratory-related outcome measures
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Rochesterlead
- Halcyon Hill Foundationcollaborator
Study Sites (1)
University of Rochester
Rochester, New York, 14642, United States
Results Point of Contact
- Title
- Dr. Jill Halterman
- Organization
- University of Rochester
Study Officials
- PRINCIPAL INVESTIGATOR
Jill S. Halterman, MD, MPH
University of Rochester
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
July 10, 2007
First Posted
July 12, 2007
Study Start
February 1, 2007
Primary Completion
June 1, 2015
Study Completion
June 1, 2015
Last Updated
November 23, 2015
Results First Posted
November 23, 2015
Record last verified: 2015-10